WO2008130583A1 - Contenant pour injecteur automatique - Google Patents
Contenant pour injecteur automatique Download PDFInfo
- Publication number
- WO2008130583A1 WO2008130583A1 PCT/US2008/004936 US2008004936W WO2008130583A1 WO 2008130583 A1 WO2008130583 A1 WO 2008130583A1 US 2008004936 W US2008004936 W US 2008004936W WO 2008130583 A1 WO2008130583 A1 WO 2008130583A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- cap
- automatic injector
- pair
- top portion
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 claims description 6
- 238000005096 rolling process Methods 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 3
- 230000005540 biological transmission Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 description 14
- 239000003814 drug Substances 0.000 description 12
- 229940124597 therapeutic agent Drugs 0.000 description 10
- 230000004913 activation Effects 0.000 description 8
- -1 polyethylenes Polymers 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 229920001893 acrylonitrile styrene Polymers 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229920006218 cellulose propionate Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 229940015979 epipen Drugs 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229920006213 ethylene-alphaolefin copolymer Polymers 0.000 description 1
- 229920005680 ethylene-methyl methacrylate copolymer Polymers 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003958 nerve gas Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920006216 polyvinyl aromatic Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920001290 polyvinyl ester Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 229920006215 polyvinyl ketone Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 229920006214 polyvinylidene halide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
- B65D25/20—External fittings
- B65D25/22—External fittings for facilitating lifting or suspending of containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D47/00—Closures with filling and discharging, or with discharging, devices
- B65D47/04—Closures with discharging devices other than pumps
- B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
- B65D47/08—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures
- B65D47/0804—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures integrally formed with the base element provided with the spout or discharge passage
- B65D47/0809—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures integrally formed with the base element provided with the spout or discharge passage and elastically biased towards both the open and the closed positions
- B65D47/0814—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having articulated or hinged closures integrally formed with the base element provided with the spout or discharge passage and elastically biased towards both the open and the closed positions by at least three hinge sections, at least one having a length different from the others
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D59/00—Plugs, sleeves, caps, or like rigid or semi-rigid elements for protecting parts of articles or for bundling articles, e.g. protectors for screw-threads, end caps for tubes or for bundling rod-shaped articles
- B65D59/04—Sleeves, e.g. postal tubes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D61/00—External frames or supports adapted to be assembled around, or applied to, articles
Definitions
- the invention relates generally to containers for carrying, storing, and protecting automatic injectors. Specifically, the invention relates to containers that allow users to open and close the containers quickly and easily and to carry and store used and unused automatic injectors safely. The invention also relates to an attachment device for carrying two of the containers together.
- an automatic injector is a device that performs intramuscular or subcutaneous administration of a therapeutic agent.
- An advantage of automatic injectors is that they contain a measured dose of a therapeutic agent in a sealed sterile cartridge. Automatic injectors allow for quick and simple injection of the therapeutic agent in emergency situations without the user having to measure dosages or see the needle as the agent is being injected. Automatic injectors are used, for example, to treat anaphylactic (severe allergic) reactions and to administer antidotes for certain poisons, such as chemical nerve gas.
- an automatic injector In those cases where an automatic injector is carried by an individual at all times, the injector is likely to be exposed to various physical and environmental stresses that may damage the injector or the therapeutic agent stored inside. For example, exposure to heat and light may cause the therapeutic agent stored inside the injector to degrade. Also, an automatic injector may inadvertently activate if dropped or jostled. And once the automatic injector has been discharged, exposure to the used needle is a risk that should be prevented in those injectors that do not have a needle cover to automatically extend over the used needle. [0005] Many automatic injectors are therefore stored, before and after use, in a container referred to as a carry pack. In general, there are two types of automatic injector carry packs.
- the first type is a soft carry pack, usually made of neoprene or other soft material. These carry packs are usually large in size and attach to a belt or other item of clothing. To access the stored injector, the user must unzip the carry pack. Unfortunately, many soft carry packs are not puncture resistant and thus cannot be used to store a discharged automatic injector with an exposed needle.
- the second type of carry pack is a smaller, tube-shaped container that can fit easily into an individual's pocket.
- the tube-shaped containers are usually made of a rigid material and are generally equipped with one of two types of caps. The first is a screw cap which requires the user to unscrew the cap, and the second is a push-cap which requires the user to remove the cap completely from the body of the container.
- containers for automatic injectors store and protect the injectors from damage and protect the therapeutic agent stored inside the injector from degradation and contamination. Also, containers of the invention help prevent the automatic injector stored therein from accidentally activating. Furthermore, the containers allow the user or caregiver to quickly open the container and remove the automatic injector stored therein and then, depending on the type of automatic injector, safely store a used injector with an exposed needle after use until proper disposal can be made.
- the automatic injector containers have a cylindrically-shaped, enclosed hollow body having an open end and a closed end opposite the open end. The closed end is preferably puncture resistant, and the open end is sized to receive an automatic injector there through.
- the body of the container includes a lower portion extending from the puncture resistant end that is preferably sized and shaped to receive only the needle end of the injector.
- the containers of the invention include a cap that has a top portion, a bottom portion, and a hinge connecting the top and bottom portions. The bottom portion is affixed to the open end of the body and the top portion is sized and shaped to close the open end of the body.
- the cap also has a front and a back, with the hinge located on the back. The front bottom portion of the cap may extend farther along the body in a direction toward the closed end than the back bottom portion of the cap to facilitate tactile identification of the front of the container.
- the hinged cap advantageously allows the user or caregiver to single-handedly open the container and access the automatic injector.
- the hinged cap has automatic spring assist features that help open and close the cap. When the user or caregiver applies sufficient force to initially open the cap (i.e., unsnap the cap from the container), the hinge causes the cap to automatically spring farther open to a position that creates a clear path unobstructed by the cap. This allows the automatic injector to be easily and quickly removed (as compared to known containers where unsnapping the cap only partially opens the cap, leaving the path at least partially blocked by the cap).
- the hinge causes the cap to automatically spring farther to a partially-closed position that prevents the automatic injector from falling out of the container, such as, for example, when the container is tilted or held at an angle that would otherwise allow the injector to slide or drop out of the container.
- Other advantageous features of the container include a body that has a shape to
- the body also has a puncture resistant bottom end to (1) prevent an unused automatic injector from piercing the container should it unintentionally activate while in the container and (2) ensure that discharged automatic injectors with exposed needles can be safely stored.
- the puncture resistant end is contoured in such a way as to bias the needle end of the automatic injector off-center, thereby making the needle more likely to bend or cripple than to penetrate the bottom end of the container.
- the body includes contours and textures that make grasping and handling of the container easier and help the user or caregiver identify the orientation of the container by feel alone.
- the contours and textures may also help identify the type of automatic injector stored inside the container and may help differentiate between the packaging and the automatic injector itself.
- the containers include a first pair of contoured areas and/or a second pair of contoured areas on the exterior surface of the body.
- the first pair of contoured areas are preferably positioned opposite each other on the body and are sized and shaped to facilitate attachment to an optional attachment device of the invention, which can be used to attach pairs of automatic injector containers together and/or one or more containers to an individual's belt, jacket, or other article of clothing or personal possession (e.g., a backpack).
- the second pair of contoured areas may also be positioned opposite each other on the body and are sized and shaped to facilitate grasping and/or orienting of the container by hand.
- the first and second pairs of contoured areas are positioned preferably opposite each on the body of the container.
- the invention is also directed to automatic injector kits that include an automatic injector, a container for the automatic injector, and an attachment device.
- FIG. 1 is a rear perspective view of an embodiment of an automatic injector container according to the invention.
- FIG. 2 is a front elevational view of another embodiment of an automatic injector container according to the invention.
- FIG. 3 is a front perspective view of an opened cap attached to a body of an automatic injector container
- FIG. 4 is a side elevational view of an opened cap
- FIG. 5 is a top view of an opened cap
- FIG. 6 is a perspective view of the automatic injector container of FIG. 2;
- FIG. 7 is a cross-sectional perspective view of a body of an automatic injector container
- FIG. 8 is a cross-sectional perspective view of a puncture resistant bottom end of an automatic injector container
- FIG. 9 is a perspective view of an attachment device according to the invention.
- FIG. 10 is a perspective view of a container attached to an attachment device.
- FIG. 11 is a perspective view of two containers attached to an attachment device.
- Automatic injector containers of the invention can store many types of automatic injectors, such as, for example, the EPIPEN ® automatic injectors by Meridian Medical Technologies, Inc.
- Typical automatic injectors have a housing that contains a cartridge.
- the cartridge has one or more chambers containing a therapeutic agent.
- the housing has a needle end that usually contains a needle assembly attached to a chamber.
- the housing also has an activation end opposite the needle end that usually contains an activation assembly.
- the activation assembly includes a stored energy source such as a compressed spring. Activation of the activation assembly typically causes a sequence of internal movements within the housing that forces the needle into a user and the therapeutic agent through the needle.
- FIG. 1 shows an embodiment of an automatic injector container according to the invention.
- Container 10 includes a preferably cylindrically-shaped, enclosed body 12 and a cap 14.
- Body 12 has an open end (not shown) covered by the cap and a preferably puncture resistant bottom end 20 opposite the open end.
- Body 12 preferably has a first pair of contoured areas 22 positioned opposite each other on the exterior surface 24 of body 12.
- Body 12 also preferably has a second pair of contoured areas 26 positioned opposite each other on exterior surface 24 (note that only one of the second pair of contoured areas 26 is shown in FIG. 1).
- Contoured areas 22 and 26 are further preferably positioned opposite each other on exterior surface 24.
- Body 12 has a preferably cylindrically-oval shape to prevent or at least inhibit container 10 from rolling on level and slightly inclined surfaces.
- Container 10 is sized to receive and enclose an automatic injector therein.
- the container is longer in the longitudinal direction than an automatic injector received therein. A user is then encouraged to tip the automatic injector out of the container rather than reach into the container to grasp the automatic injector. This is preferred because some automatic injectors have a safety pin located at the end of the injector nearest the open end of the container (i.e., opposite the needle end).
- FIG. 2 shows another embodiment of an automatic injector container according to the invention.
- Container 10X which is substantially similar to container 10, also includes enclosed body 12, cap 14, puncture resistant end 20, and first pair of contoured areas 22.
- container 1OX has a second pair of differently shaped contoured areas 25 positioned opposite each other on exterior surface 24. Contoured areas 25 do not extend down to puncture resistant end 20 on the sides of the container where contoured areas 22 are located as do contoured areas 26 of container 10. This difference allows the thickness of the tube wall section in those areas to be increased, which may help maintain wall symmetry during a molding process of the container.
- Cap 14 includes a top portion 30, a bottom portion 32, and a hinge 34.
- Hinge 34 connects top portion 30 to bottom portion 32.
- the cap has a front 16 and a back 18, and hinge 34 is located on back 18 of cap 14.
- the back of cap 14 is aligned longitudinally with one of the second pair of contoured areas 25/26
- the front of cap 14 is aligned longitudinally with the other of the second pair of contoured areas 25/26.
- Bottom portion 32 is affixed to the top, open end of container 10/ 1OX (referred to collectively hereinafter as "the container” or just “container 10").
- the cap can be any shape, provided it uses the hinge mechanism of the invention and securely attaches to (and in some cases provides an airtight seal with) the body of the container when closed.
- the front 16, bottom portion 32 of cap 14 preferably extends farther along body 12 in a direction toward puncture resistant end 20 than the back 18, bottom portion 32 of cap 14.
- Cap 14 also has a flap 35 located on the front 16, top portion 30 and has a contoured area 38 located on the front 16, bottom portion 32. Contoured area 38 allows the user to identify the front of the cap, as well as easily engage the flap to open the cap for easy access or disposal of an automatic injector. Also, such a feature advantageously allows the user to single-handedly open the container for access or disposal of an automatic injector.
- FIG. 3 shows cap 14 in an open position. Bottom portion 32 of the cap is affixed to open end 36 of body 12. In some embodiments, as shown in FIG. 3, open end 36 extends beyond (i.e., above) bottom portion 32 of cap 14. This extension protects the automatic injector from accidental activation while cap 14 is opened or closed. A rim 40 located on the front 16, top portion 30 of the cap snap- fits into a groove 42 located on the front 16, bottom portion 32 of the cap. Other fastening mechanisms can be used provided that they secure the top portion of the cap to the bottom portion of the cap so the container body is closed and in some cases sealed. Cap 14 advantageously provides for repeated opening and closing of open end 36 of body 12.
- the spring assist feature of the hinge provides the cap with an automatic spring-open state and an automatic spring-almost-closed state.
- the spring-open state allows the automatic injector to be easily removed from the container, because the injector is not obstructed by the top portion of the cap when the cap is in the spring-open state.
- the spring-almost-closed state prevents the injector from falling out of the container, such as, for example, when the top of the container is tipped downward or while a person holding or carrying the container is running or otherwise moving, because the position of the cap in the almost-closed state blocks the exit path of the injector.
- FIG. 4 shows the cap in an open state.
- Hinge 34 includes a primary support 50 and a secondary support 54.
- the top portion of the cap when the cap is closed (i.e., snapped shut), the container is not air tight (i.e., not hermetically sealed).
- the cap when the cap is closed (i.e., snapped shut), the container is not air tight (i.e., not hermetically sealed).
- the cap when the cap is closed (i.e., snapped shut), the container is not air tight (i.e., not hermetically sealed).
- the cap includes a vent hole.
- FIG. 5 shows an open cap 14 with top portion 30, bottom portion 32, and hinge 34 with primary support 50 and secondary support 54.
- Cap 14 has a vent hole 48 located on hinge 34.
- a vent hole allows the container to vent and alleviate any pressure that may build up within the container, as well as prevent any volatiles that may be present from affecting the therapeutic agent in the injector.
- the vent hole can be alternatively located on other areas of the cap, such as on the top or bottom portion of the cap or on the body of the injector container.
- containers of the invention may have more than one vent hole.
- the cap preferably include features to prevent an automatic injector from rattling (i.e., moving freely) within the container.
- cap 14 preferably has two internal walls or ridges 56. As the cap is closed, ridges 56 contact the top of the automatic injector and, if needed, push the injector fully into position in the container. When the cap is closed, internal walls 56 continue to contact the top of the automatic injector to secure the position of the injector within the container and prevent the injector from moving around within the closed container.
- FIG. 6 shows body 12 of the container. Body 12 is a cylindrically-shaped, enclosed hollow structure with an exterior surface 24, an open end 36 and a puncture resistant end 20 opposite the open end.
- Open end 36 is sized to receive an automatic injector there through.
- the lower portion of the body extending from the puncture resistant end is preferably sized and shaped to receive only the needle end of the automatic injector.
- the automatic injector can only be fully received within the container if properly oriented needle end first when inserted. This advantageous feature helps avoid injury or contamination by preventing a user from first handling the needle end of the injector upon removal from the container or from handling the needle end upon return of the used injector back into the container.
- body 12 Located on exterior surface 24 of body 12 is at least one contoured area.
- body 12 has a first pair of contoured areas 22 positioned opposite each other on exterior surface 24 (note that only one of the first pair of contoured areas is shown).
- Contoured areas 22 are sized and shaped to facilitate attachment to an attachment device and are positioned on exterior surface 24 preferably somewhat higher than midway between open end 36 and puncture resistant end 20.
- the body also includes a second pair of contoured areas 25 positioned opposite each other on exterior surface 24 of body 12 (note also that only one of the second pair of contoured areas is shown).
- Contoured areas 25 are positioned on exterior surface 24 preferably proximal to puncture resistant end 20 and are sized and shaped to facilitate grasping of the container by hand.
- the contoured areas can have different textures than the rest of the body.
- the second pair of contoured areas can have a rougher texture than other areas of the body. Varying the texture can increase tactility and help encourage grip. Also, varying the texture can prevent the user or caregiver from becoming confused between the packaging and the injector. For example, rough or "sparked" areas (that create, e.g., a frosted finish) can obscure or blur the label of the automatic injector itself and thus make the user or caregiver aware that the container is not the automatic injector and that the injector is inside the container.
- puncture resistant end 20 preferably has a base 64 with a raised middle portion 65.
- This form of puncture resistant end causes the needle end of an automatic injector to be off center. Off centering the needle end of the injector weakens the puncturing force of the needle, thus the needle is more likely to bend and/or cripple than penetrate the container.
- the base of the puncture resistant end may be alternatively of other shapes that cause the needle end of the automatic injector to be off-center.
- the base can include raised portions, peaks, troughs, dimples, or rough textures.
- the puncture resistant end may have a body wall thicker than the rest of the body.
- the body wall of the puncture resistant end should be thick enough to withstand the force of a needle driven by an inadvertent activation of an automatic injector inside the container (i.e., thick enough to prevent the needle from piercing through the puncture resistant end as the needle extends outward from the injector under the force of the injector's activation assembly).
- the increased thickness of the body wall at the puncture resistant end can be formed by the same material as the body or, alternatively, the increased thickness may be formed by an insert made of a different material than the body.
- body 12 preferably includes additional features such as at least one internal rib 66 that extends longitudinally from open end 36 toward puncture resistant end 20.
- Rib 66 provides clearance for a safety pin or release of an automatic injector (i.e., so the safety pin or release is not dislodged by the wall of the container as the injector is inserted) and ensures correct alignment when inserting the injector into the container. Rib 66 also prevents the automatic injector from moving within the container. Rib 66 further allows the automatic injector to safely and easily slide into and out of the container by reducing drag, friction, and/or snagging.
- FIG. 8 shows an embodiment of puncture resistant end 20 of body 12 that includes a pair of ridges 68. Ridges 68 advantageously protect the components of an automatic injector stored within the container from shock loads.
- FIG. 9 shows an optional attachment device of the invention that can be used to hold together a pair of injector containers.
- the attachment device is an S-shaped clip 100 having a first section 1 10, a middle section 120 and a second section 130.
- the first section 1 10 and middle section 120 are sized, shaped and spaced apart from each other such that a container can be securely held via a friction fit between the first and middle sections.
- the middle and second sections 120, 130 are also sized, shaped and spaced apart from each other such that a container can be securely held via a friction fit between the middle and second sections.
- the spacings between sections are slightly less than the width of the container, thus requiring the sections to be flexed apart somewhat when attaching the container.
- the clip has a spring-like resiliency that holds the container(s) securely in place.
- the attachment device may be formed from any suitable material that permits clip 100 to flex and engage the side of the container with a friction fit.
- the first and middle sections 110, 120 may have a different radius of curvature than that of the containers. The different radiuses of curvature between the first and middle sections 110, 120 and the containers allow clip 100 to engage a container with minimal contact between the first and middle sections 110, 120 and the containers. Such minimal contact reduces the likelihood that first section 110 and middle section 120 will scratch the contours of the container. The same is preferably true for the radiuses of curvature of the middle and second sections 120, 130.
- the overall "S" shape of the clip reduces the amount of force needed to remove a container from the clip, as compared to a more conventional double C-clip.
- the "S" shape of the clip allows the containers to act as levers, making removal of the containers easy. Additionally, texture on the outer surface of the attachment device makes the device easy to grip and preferably encourages users to replace the containers in the attachment device once the automatic injector has been used.
- the attachment device can also include a suitable attachment assembly for carrying the device on a belt or otherwise securing the device to an article of clothing or personal possession, such as a back or fanny pack.
- FIG. 10 shows one container secured within an attachment device.
- Container 1OX is securely held via a friction fit between the first and middle sections of S-clip 100.
- First section 110 engages one of the contoured areas 22 of container 10 and middle section 120 engages the other contoured area 22.
- FIG. 1 1 shows a first container and a second container secured within an attachment device.
- First container 150 and second container 160 are securely held via respective friction fits within S-clip 100 simultaneously.
- First container 150 is held between first section 1 10 and middle section 120 of S-clip 100.
- First section 1 10 engages one of the pair of contoured areas 122 of first container 150 and middle section 120 engages the other contoured area 122.
- Second container 160 is held between middle section 120 and second section 130 of S-clip 100.
- Middle section 120 engages one of the pair of contoured areas 124 of container 160 and second section 130 engages the other contoured area 124.
- first and second containers 150,160 are held in S-shaped clip 100 such that respective caps 152 and 162 of first 150 and second 160 containers are adjacent to each other. Also, first and second containers 150, 160 are held in the S-shaped clip such that hinge 154 of first container cap 152 faces a direction opposite the direction in which hinge 164 of second container cap 162 faces. Alternatively, the first and second containers can be held in the S-shaped clip such that the hinge of the first container faces the same direction as the hinge of the second container cap. Further still, the first and second containers can be held upside down with respect to each other. In any case, both containers can be advantageously opened and closed without having to remove the container from the S-clip.
- the containers of the invention can be made of any suitable material. Suitable materials include those that can form a container as described herein and that will safely contain an automatic injector before and, depending on the size and type of injector, after use. Suitable materials include, but are not limited to, polymers. Suitable polymers include, but are not limited to, polyurethanes, polyisobutylene and its copolymers, silicones, polyethylenes and polyesters.
- polystyrene copolymers include polyolefins, polyisobutylene, ethylene- alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers and copolymers such as polyvinyl chloride, polyvinyl ethers such as polyvinyl methyl ether, polyvinylidene halides such as polyvinylidene fluoride and polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics such as polystyrene, polyvinyl esters such as polyvinyl acetate; copolymers of vinyl monomers, copolymers of vinyl monomers and olefins such as ethylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS resins, ethylene-vinyl acetate copolymers, polyamides such as Nylon 66 and polycaprolactone, alkyd resins
- the cap and body of the containers can be made of the same or different materials.
- the cap may be made of polypropylene and the container may be made of polyester or poly(ethylene terephthalate) (PET).
- PET poly(ethylene terephthalate)
- the cap and body of the containers are preferably made of a material capable of blocking, absorbing or otherwise inhibiting the transmission of at least some wavelengths of ultraviolet (UV) light.
- a UV absorbing agent can be added to the polymer from which the cap and the container are formed. UV blocking or absorbing capability helps to ensure that the therapeutic agent within the automatic injector is not degraded or otherwise compromised by exposure to UV light, even if the container is significantly light permeable.
- the containers of the invention may also be made of a transparent, translucent or opaque material, or any combination thereof.
- the caps of the containers can be made from an opaque, colored material. Using colored caps can help a user or caregiver easily identify which type of automatic injector is in which container.
- the body can be a combination of transparent material and translucent material. Transparent material can form windows through the container so that the user can (1) identify what type of automatic injector is in the container, (2) determine whether it has been used and/or (3) read the instructions on the injector.
- the containers of the invention may also serve as product packaging for an automatic injector and can thus be distributed with an automatic injector inside.
- the exterior surfaces of the body of the containers, as well as the caps of the containers can be used for product labeling, usage directions, or other necessary indicia.
- labeling can be printed on labels and then affixed to the containers or printed or otherwise directly imposed on the surfaces of the containers during manufacture.
- transparent windows can be used as branding areas to display trademarks or other branding materials.
- translucent textured material may be used to form particular portions of the container, such as, for example, the contoured areas where the user is most likely to grasp or hold the container. Using a textured surface on portions of the container increases the user's ability to grasp and hold on to the container.
- Containers of the invention may have other useful features. As shown in
- FIGS. 1, 2, 6, 10, and 11, body 12 may have a pair of oppositely positioned semi-spherical nubs 27 on the lower portion of exterior surface 24 (note that, because of the particular views shown, only one nub is seen in FIGS. 1, 2, 6, 10, and 1 1). Nubs 27 help prevent the containers from nesting or interlocking with other containers during manufacturing, assembly, and packaging.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2008241466A AU2008241466A1 (en) | 2007-04-18 | 2008-04-17 | Container for an automatic injector |
EP08742983A EP2155302A1 (fr) | 2007-04-18 | 2008-04-17 | Contenant pour injecteur automatique |
JP2010504081A JP2010524566A (ja) | 2007-04-18 | 2008-04-17 | 自動注射器用の容器 |
CA002683949A CA2683949A1 (fr) | 2007-04-18 | 2008-04-17 | Contenant pour injecteur automatique |
IL201582A IL201582A0 (en) | 2007-04-18 | 2009-10-15 | Container for an automatic injector |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92528307P | 2007-04-18 | 2007-04-18 | |
US60/925,283 | 2007-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008130583A1 true WO2008130583A1 (fr) | 2008-10-30 |
WO2008130583A8 WO2008130583A8 (fr) | 2009-05-28 |
Family
ID=39875808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/004936 WO2008130583A1 (fr) | 2007-04-18 | 2008-04-17 | Contenant pour injecteur automatique |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080289984A1 (fr) |
EP (1) | EP2155302A1 (fr) |
JP (1) | JP2010524566A (fr) |
AU (1) | AU2008241466A1 (fr) |
CA (1) | CA2683949A1 (fr) |
IL (1) | IL201582A0 (fr) |
TW (1) | TW200902110A (fr) |
WO (1) | WO2008130583A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012010797A1 (fr) * | 2010-07-21 | 2012-01-26 | Babolat Vs | Boîte de balles ou analogues pour sport de raquette |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8361026B2 (en) | 2005-02-01 | 2013-01-29 | Intelliject, Inc. | Apparatus and methods for self-administration of vaccines and other medicaments |
CN105327432B (zh) * | 2010-03-31 | 2018-11-30 | Shl集团有限责任公司 | 包括反馈信号装置的药物输送设备 |
SE534586C2 (sv) * | 2010-08-10 | 2011-10-11 | Charles Ruben | Set för medicinsk behandling innefattande behållare för kanyler |
WO2012089821A1 (fr) | 2010-12-31 | 2012-07-05 | Novo Nordisk A/S | Dispositif médical d'injection |
US20130292294A1 (en) * | 2012-05-03 | 2013-11-07 | Brandon J. Wilson | Allergy emergency kit |
CA2917047C (fr) | 2013-08-30 | 2019-06-11 | Hollister Incorporated | Dispositif d'irrigation transanale |
US9656016B2 (en) | 2014-01-29 | 2017-05-23 | Beckton, Dickinson And Company | Syringe packaging system including oxygen absorber |
CA3217507A1 (fr) | 2014-05-30 | 2015-12-03 | Hollister Incorporated | Emballage de catheter a ouverture par soulevement |
AU2015287992B2 (en) | 2014-07-08 | 2020-03-12 | Hollister Incorporated | Trans anal irrigation platform with bed module |
EP3166661B1 (fr) | 2014-07-08 | 2019-01-09 | Hollister Incorporated | Dispositif d'irrigation trans-anale portable |
USD820583S1 (en) * | 2016-04-22 | 2018-06-19 | Hollister Incorporated | Catheter package with twist cap |
WO2017185052A1 (fr) | 2016-04-22 | 2017-10-26 | Hollister Incorporated | Emballage de dispositif médical à capuchon rabattable à encliquetage |
USD828011S1 (en) * | 2016-04-22 | 2018-09-11 | Hollister Incorporated | Catheter package with flip cap |
CA3021640A1 (fr) | 2016-04-22 | 2017-10-26 | Hollister Incorporated | Emballage de dispositif medical dote d'une capsule a vis |
LT3481460T (lt) | 2016-07-08 | 2020-07-27 | Hollister Incorporated | Bevielis elektroninis siurblys, skirtas kūno ertmės irigacijos aparatui |
WO2018111713A1 (fr) | 2016-12-14 | 2018-06-21 | Hollister Incorporated | Dispositif et système d'irrigation transanale |
USD841155S1 (en) | 2017-01-30 | 2019-02-19 | Hollister Incorporated | Catheter package with twist cap |
USD841156S1 (en) | 2017-01-30 | 2019-02-19 | Hollister Incorporated | Catheter package with flip cap |
AU2018225550B2 (en) * | 2017-02-21 | 2023-07-06 | Hollister Incorporated | Medical device package with flip cap having a snap fit |
CN115837107A (zh) | 2017-06-30 | 2023-03-24 | 里珍纳龙药品有限公司 | 具有防滚特征的自动注射器 |
JP1629603S (fr) | 2017-10-25 | 2019-04-15 | ||
LT3720536T (lt) | 2017-12-08 | 2024-09-10 | Hollister Incorporated | Medicinos prietaiso pakuotė, skirta ergonominiam prietaiso išėmimui |
EP3768357A4 (fr) * | 2018-03-22 | 2022-01-05 | BDRtech LLC | Dispositif d'auto-injection |
USD932006S1 (en) | 2018-11-21 | 2021-09-28 | Regeneron Pharmaceuticals, Inc. | Auto-injector cap |
USD903856S1 (en) | 2018-06-29 | 2020-12-01 | Regeneron Pharmaceuticals, Inc. | Auto-injector |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137516A (en) * | 1989-11-28 | 1992-08-11 | Glaxo Group Limited | Triggered application device for medicament to be more descriptive of the invention |
US20050148933A1 (en) * | 2003-11-04 | 2005-07-07 | Raven Sophie R. | Container for medicament automatic injector and automatic injector adapted therefor |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1711594A (en) * | 1927-04-28 | 1929-05-07 | Holden T Gillespie | Syringe container |
US3346135A (en) * | 1964-08-10 | 1967-10-10 | Richardson Merrell Inc | Dual function stopper |
US3275180A (en) * | 1965-01-04 | 1966-09-27 | Lermer Packaging Corp | Mailing container construction |
US3933271A (en) * | 1974-02-14 | 1976-01-20 | Colgate-Palmolive Company | Captive cap |
US4377247A (en) * | 1978-10-31 | 1983-03-22 | Polytop Corporation | Dispensing closure employing living hinge |
DE2936717A1 (de) * | 1979-09-11 | 1981-03-12 | Nova-Handels AG, Zürich | Verschluss fuer flaschen. |
US4625898A (en) * | 1984-09-11 | 1986-12-02 | Polytop Corporation | Dispensing closure employing living hinge with cams to momentarily deform hinge and recesses to accept cams |
US4711360A (en) * | 1987-02-26 | 1987-12-08 | Boardman Molded Products, Inc. | Splash-proof closure |
US4742928A (en) * | 1987-06-11 | 1988-05-10 | W. Braun Company | Dispensing closure with articulated flip-top cap |
US4813560A (en) * | 1988-05-04 | 1989-03-21 | Continental White Cap, Inc. | Spring hinge for dispensing cap |
US5172808A (en) * | 1988-07-01 | 1992-12-22 | John Bruno | Device for safely transporting one or more hypodermic needles or the like from point of use to point of ultimate disposal |
US5019051A (en) * | 1989-03-02 | 1991-05-28 | Needlepoint Guard, Inc. | Hypodermic needle guard |
US5083671A (en) * | 1989-12-13 | 1992-01-28 | Anchor Hocking Packaging Company | Closure for a wide mouth container |
US5407087A (en) * | 1992-12-30 | 1995-04-18 | Lever Brothers Company, Division Of Conopco, Inc. | Venting closure |
CH687253A5 (de) * | 1993-03-30 | 1996-10-31 | Createchnic Ag | Kunststoffverschluss. |
US5417326A (en) * | 1994-03-31 | 1995-05-23 | Winer; Donald B. | Syringe container |
DE4419116C2 (de) * | 1994-06-01 | 1996-03-28 | Riegler Fritz A Gmbh & Co | Behälterverschluß |
US5819921A (en) * | 1996-12-12 | 1998-10-13 | Centrix, Inc. | Calcium hydroxide package and method of forming same |
US5775498A (en) * | 1997-07-31 | 1998-07-07 | Kashanchi; Behnam | Hypodermic needle storage apparatus |
USD428650S (en) * | 1998-09-08 | 2000-07-25 | Powderject Research Limited | Injector |
CA2251863A1 (fr) * | 1998-10-20 | 2000-04-20 | Zoni Inc. | Systeme de ceinture pour loger un dispositif medical |
USD440494S1 (en) * | 1999-11-29 | 2001-04-17 | The Procter & Gamble Company | Closure |
US20040069667A1 (en) * | 2000-05-12 | 2004-04-15 | Tomellini Dalita R. | Cases for medication delivery devices |
JP4159235B2 (ja) * | 2000-09-04 | 2008-10-01 | エム・エフ・ヴィ株式会社 | ヒンジキャップ |
US20030222228A1 (en) * | 2001-12-05 | 2003-12-04 | Chen Fu Monty Mong | Apparatus and method for transporting radiopharmaceuticals |
CA100541S (en) * | 2002-03-09 | 2003-08-27 | Aventis Pharma Deutschland Gmbh | Case for medication delivery device |
AU2003282463A1 (en) * | 2002-10-17 | 2004-05-04 | Mallinckrodt Inc. | Polymer pharmaceutical pig and associated method of use and associated method of production |
US6923582B2 (en) * | 2003-10-21 | 2005-08-02 | Cartec International, Inc. | Inked ribbon core |
USD509352S1 (en) * | 2003-11-07 | 2005-09-13 | Meridan Medical Technologies, Inc. | Automatic injector container |
USD506309S1 (en) * | 2004-02-04 | 2005-06-21 | Meridian Medical Technologies Inc. | Case for an injection device |
JP4658507B2 (ja) * | 2004-03-31 | 2011-03-23 | 竹本容器株式会社 | 自開式キャップ機構 |
US8006853B2 (en) * | 2005-05-09 | 2011-08-30 | L'oreal | Closure cap and a receptacle fitted therewith |
USD524037S1 (en) * | 2005-05-13 | 2006-07-04 | Richard Van Horn | Earplug dispenser |
-
2008
- 2008-04-17 US US12/104,523 patent/US20080289984A1/en not_active Abandoned
- 2008-04-17 WO PCT/US2008/004936 patent/WO2008130583A1/fr active Application Filing
- 2008-04-17 AU AU2008241466A patent/AU2008241466A1/en not_active Abandoned
- 2008-04-17 JP JP2010504081A patent/JP2010524566A/ja active Pending
- 2008-04-17 CA CA002683949A patent/CA2683949A1/fr not_active Abandoned
- 2008-04-17 EP EP08742983A patent/EP2155302A1/fr not_active Withdrawn
- 2008-04-18 TW TW097114325A patent/TW200902110A/zh unknown
-
2009
- 2009-10-15 IL IL201582A patent/IL201582A0/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137516A (en) * | 1989-11-28 | 1992-08-11 | Glaxo Group Limited | Triggered application device for medicament to be more descriptive of the invention |
US20050148933A1 (en) * | 2003-11-04 | 2005-07-07 | Raven Sophie R. | Container for medicament automatic injector and automatic injector adapted therefor |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012010797A1 (fr) * | 2010-07-21 | 2012-01-26 | Babolat Vs | Boîte de balles ou analogues pour sport de raquette |
FR2962984A1 (fr) * | 2010-07-21 | 2012-01-27 | Babolat Vs | Capuchon de boite de balles de tennis et boite de balles comportant un tel capuchon |
JP2013536130A (ja) * | 2010-07-21 | 2013-09-19 | バボラ ヴイエス | ラケットスポーツにおけるボール等のための缶 |
Also Published As
Publication number | Publication date |
---|---|
WO2008130583A8 (fr) | 2009-05-28 |
JP2010524566A (ja) | 2010-07-22 |
EP2155302A1 (fr) | 2010-02-24 |
AU2008241466A1 (en) | 2008-10-30 |
CA2683949A1 (fr) | 2008-10-30 |
TW200902110A (en) | 2009-01-16 |
US20080289984A1 (en) | 2008-11-27 |
IL201582A0 (en) | 2010-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080289984A1 (en) | Container for an automatic injector | |
US7635348B2 (en) | Container for medicament automatic injector and automatic injector adapted therefor | |
US7780637B2 (en) | Medical device container | |
US5590782A (en) | Vial holder assembly | |
KR100363601B1 (ko) | 투명구역을구비한힌지된용기 | |
JP4949029B2 (ja) | コンタクトレンズケアシステム | |
JP6742365B2 (ja) | ペンニードルパッケージ | |
EP2337599B1 (fr) | Contenant pour dispositif d'injection muni d'une aiguille d'injection | |
RU1804432C (ru) | Защищенный от неумелого обращени контейнер дл индивидуальных упаковок с контактными линзами | |
EP2420268B1 (fr) | Magasin pour aiguilles d'injéction | |
US20040069667A1 (en) | Cases for medication delivery devices | |
EP2078685A1 (fr) | Récipient réutilisable pour doses unitaires pour adultes, avec sécurité-enfants | |
JP2015504703A (ja) | 針チップの格納除去デバイス | |
NO174323C (no) | Beskyttende beholder for oppbevaring av en glassampulle for medikamenter | |
CA2173349A1 (fr) | Dispositif de securite permettant de confiner notamment des seringues hypodermiques | |
US20120292205A1 (en) | Lighted glasses case | |
AU741793B2 (en) | Improved syringe storage and disposal container | |
KR200237645Y1 (ko) | 방독마스크용 누드 필터 포장용기 | |
KR200440836Y1 (ko) | 약제 케이스 | |
GB2341942A (en) | Case for contact lenses or other articles | |
KR200185047Y1 (ko) | 포켓 휴대용 정제 케이스 | |
KR20070032266A (ko) | 약물 자동 주사기 용기 및 자동 주사기 | |
JP2006273342A (ja) | 引出構造センサーチップ容器 | |
KR20110011187U (ko) | 앰풀 케이스 | |
CA2324991A1 (fr) | Dispositif a emballage de balles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08742983 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2683949 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201582 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2010504081 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008241466 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008742983 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2008241466 Country of ref document: AU Date of ref document: 20080417 Kind code of ref document: A |